SS&C Technologies Holdings, Inc. SSNC ← Back to all reports

SS&C Technologies Holdings, Inc.

SSNC · Technology
S ★★★★★ Strong Buy
Jul 26, 2026 · Score 96 · Type A — Value-style analysis Used for established, cash-generative companies — weighs earnings power, valuation against the company's own history and peers, and margin of safety. Full methodology →
Current PriceThe market price around the time this report was written — not a live quote. The market has moved since; check a current price before acting.Methodology → $73.88
Buy ZoneThe large figure is the midpoint of the suggested buy range shown in parentheses. $72.00 ($68.00–$76.00)
Target PriceOur estimated fair value. For richly valued stocks it can sit below the current price — see Methodology.Methodology → $107.06
Expected Return
  • Target relative to the Current Price ((Target − Current) ÷ Current). Since that price is from the report date, your actual return will differ.
  • A negative figure isn't an error. For richly valued stocks, the fair-value target can sit below the current price, so the return reads negative. The grade reflects company quality; this figure reflects today's entry valuation.
Methodology →
+44.9%

Type A - SS&C Technologies Holdings, Inc. (SSNC) 20260726 Stock Analysis

📅 SS&C Key Upcoming Events

🏢 Step 1: SS&C Company Overview & Business Model

Q1-A1. What is SS&C?

Q1-A2. How Does SS&C Make Money?

Q1-A3. SS&C’s Revenue Segments & Core Income Sources

Q1-A4. Who Are SS&C’s Competitors?

Q1-A5. SS&C Key Events: Past 12 Months

Q1-A6. Step 1 Key Takeaways

🏰 Step 2: SS&C’s Economic Moat, Growth & Capital Allocation

Q2-A1. Does SS&C Have a Durable Economic Moat?

Q2-A2. Is SS&C’s Growth Sustainable?

Q2-A3. How Does SS&C Allocate Capital & Return Cash?

Q2-A4. Step 2 Key Takeaways

💰 Step 3: Is SS&C Profitable? Financial Health Analysis

Q3-A2. How Profitable Is SS&C? (Margins & ROIC)

Q3-A3. What Drives SS&C’s Returns? (ROIC Breakdown)

Q3-A4. Are SS&C’s Earnings High Quality?

Q3-A5. Is SS&C’s Balance Sheet Healthy? (Debt & Leverage)

Q3-A6. Step 3 Key Takeaways

🔎 Step 4: SS&C Forensic Accounting & Dilution Review

Q4-A1. Does SS&C Have Accounting Red Flags?

Q4-A2. Is SS&C Overspending? (Capex & Capital Cycle)

Q4-A3. How Sound Is SS&C’s Cash Flow?

Q4-A4. Is SS&C Diluting Shareholders?

Q4-A5. Data Integrity Check

Q4-A6. Step 4 Key Takeaways

👔 Step 5: SS&C Management & Shareholder Alignment

Q5-A1. Can You Trust SS&C’s Management? (Guidance Track Record)

Q5-A2. What Are SS&C Insiders Doing?

Q5-A3. Is SS&C’s Management Aligned With Shareholders?

Q5-A4. Step 5 Key Takeaways

⛵ Step 6: SS&C Market Flow & Sentiment

Q6-A1. Analyst Consensus vs SS&C Guidance

Q6-A2. What Is SS&C’s Short Interest?

Q6-A3. Step 6 Key Takeaways

🚀 Step 7: SS&C Catalysts & Price Triggers

Q7-A1. What Could Move SS&C Stock? (Top 3 Catalysts)

Q7-A2. SS&C’s Earnings Revision Trend

Q7-A3. Step 7 Key Takeaways

⚖️ Step 8: Is SS&C Fairly Valued? Valuation Analysis

Q8-A1. SS&C’s Key Valuation Multiples (P/E, EV/EBITDA)

Q8-A2. SS&C vs Peers: Valuation Comparison

Q8-A3. Is SS&C Cheap or Expensive vs Its History?

Q8-A4. What Growth Is Priced Into SS&C? (Reverse DCF)

Q8-A5. Valuation Cross-Check

Q8-A6. SS&C’s Asset & Stake Valuation

Q8-A7. Final Valuation Adjustment

Q8-A8. Valuation Adjustment Score Calculation

💀 Step 9: What Are the Risks of SS&C? Fatal Risks & Pre-Mortem

Q9-A1. What Are the Biggest Risks to SS&C?

Q9-A2. How Sensitive Is SS&C to the Economy?

Q9-A3. SS&C Pre-Mortem: What Could Go Wrong?

Q9-A4. Risk Adjustment Score Calculation

🎯 Step 10: SS&C Final Verdict: Score & Rating

Q10-A1. Investment Score & Rating

Q10-A2. Should You Buy SS&C? (Recommendation)

Q10-A3. Investment Thesis in One Line

Q10-A4. SS&C’s Price Trend & Key Drivers

Q10-A5. Action Plan

🕵️‍♂️ Deep Dive Analysis

Q1: Is SS&C’s $7.6 Billion Debt Load Its Biggest Weakness?

Q2: Can SS&C’s 10.3x Forward P/E Be Justified by the FinTech Consolidation Cycle?

Q3: Will SS&C’s Blue Prism WorkHQ Launch Materially Accelerate Intelligent Automation Revenues?

Q4: How Resilient is SS&C GlobeOp to a Severe Alternative Asset Market Downturn?

Q5: Does SS&C’s Launch of the DomaniRx GLP-1 Bridge Program Signal a Healthcare Segment Turnaround?

Q6: Can SS&C Maintain its 39.5% EBITDA Margin Amidst Wage Inflation and AI Investments?

Q8: How Effectively is SS&C Fending off Disruptive FinTech Startups in Wealth Management?

Q9: Will SS&C’s Continued Share Buybacks Remain the Primary Driver of EPS Growth?

Q10: Are Recent SS&C Insider Sales Indicative of a Valuation Ceiling?

SS&C Technologies Holdings, Inc. (SSNC)